Several medications may interact with levothyroxine (LT4) intestinal absorption or metabolism, thus reducing its bioavailability. We investigated the variability of thyroid stimulating hormone (TSH) levels and prescribed daily dosages (PDDs) of LT4 before and during potential drug-drug interactions (DDIs) in users of tablets vs. oral liquid LT4 formulations.
Guglielmi, V., Bellia, A., Bianchini, E., Medea, G., Cricelli, I., Sbraccia, P., et al. (2018). Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care. ENDOCRINE, 59(3), 585-592 [10.1007/s12020-017-1412-4].
Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care
Guglielmi V.;Bellia A.;Sbraccia P.;Lauro D.;
2018-01-01
Abstract
Several medications may interact with levothyroxine (LT4) intestinal absorption or metabolism, thus reducing its bioavailability. We investigated the variability of thyroid stimulating hormone (TSH) levels and prescribed daily dosages (PDDs) of LT4 before and during potential drug-drug interactions (DDIs) in users of tablets vs. oral liquid LT4 formulations.| File | Dimensione | Formato | |
|---|---|---|---|
|
Liquid L-T4 Endocrine 2017.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
311.33 kB
Formato
Adobe PDF
|
311.33 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
